Profile
Barbara Y.
Chan is currently working as the CFO, CAO & Senior Vice President-Finance at Omega Therapeutics, Inc. She previously worked as the President & Director at Aegerion Pharmaceuticals, Inc. and as the Chief Accounting Officer at Novelion Therapeutics, Inc. Ms. Chan completed her undergraduate and graduate degrees at Bentley University.
Barbara Chan active positions
| Companies | Position | Start |
|---|---|---|
| OMEA THER | Director of Finance/CFO | 2024-05-30 |
Former positions of Barbara Chan
| Companies | Position | End |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Comptroller/Controller/Auditor | 2019-09-23 |
| AEGERION PHARMACEUTICALS, INC. | President | - |
Training of Barbara Chan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novelion Therapeutics, Inc.
Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets rare disease products, metreleptin and lomitapide | Health Technology |
Omega Therapeutics, Inc.
Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
- Stock Market
- Insiders
- Barbara Chan
















